121 related articles for article (PubMed ID: 11880073)
1. Effects of finasteride and cyproterone acetate on hematuria associated with benign prostatic hyperplasia: a prospective, randomized, controlled study.
Perimenis P; Gyftopoulos K; Markou S; Barbalias G
Urology; 2002 Mar; 59(3):373-7. PubMed ID: 11880073
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride.
Foley SJ; Soloman LZ; Wedderburn AW; Kashif KM; Summerton D; Basketter V; Holmes SA
J Urol; 2000 Feb; 163(2):496-8. PubMed ID: 10647664
[TBL] [Abstract][Full Text] [Related]
3. Role of finasteride in the treatment of recurrent hematuria secondary to benign prostatic hyperplasia.
Carlin BI; Bodner DR; Spirnak JP; Resnick MI
Prostate; 1997 May; 31(3):180-2. PubMed ID: 9167770
[TBL] [Abstract][Full Text] [Related]
4. Finasteride: a long-term follow-up in the treatment of recurrent hematuria associated with benign prostatic hyperplasia.
Delakas D; Lianos E; Karyotis I; Cranidis A
Urol Int; 2001; 67(1):69-72. PubMed ID: 11464120
[TBL] [Abstract][Full Text] [Related]
5. Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia.
Kearney MC; Bingham J; Bergland R; Meade-D'Alisera P; Puchner PJ
J Urol; 2002 Jun; 167(6):2489-91. PubMed ID: 11992064
[TBL] [Abstract][Full Text] [Related]
6. [Effects of finasteride on hematuria associated with benign prostatic hyperplasia: a meta-analysis].
Jiang Y; Long YF
Zhonghua Nan Ke Xue; 2010 Aug; 16(8):726-9. PubMed ID: 21090349
[TBL] [Abstract][Full Text] [Related]
7. The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report.
Puchner PJ; Miller MI
J Urol; 1995 Nov; 154(5):1779-82. PubMed ID: 7563345
[TBL] [Abstract][Full Text] [Related]
8. Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up.
Miller MI; Puchner PJ
Urology; 1998 Feb; 51(2):237-40. PubMed ID: 9495704
[TBL] [Abstract][Full Text] [Related]
9. Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia.
Memis A; Ozden C; Ozdal OL; Guzel O; Han O; Seckin S
Urol Int; 2008; 80(2):177-80. PubMed ID: 18362489
[TBL] [Abstract][Full Text] [Related]
10. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Beigi A; Sobhi A; Zarrinkoub F
Int J Gynaecol Obstet; 2004 Oct; 87(1):29-33. PubMed ID: 15464773
[TBL] [Abstract][Full Text] [Related]
11. [Finasteride: an effective therapeutic for benign prostatic hyperplasia related gross hematuria in patients receiving anticoagulant].
Lin YH; Jiang YG; Li MC; Peng T
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):31-3. PubMed ID: 19288745
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
Palou Redorta J; Gausa Gascon L; Salvador Bayarre J; Millán Rodríguez F; Segarra Tomás J; Villavicencio Mavrich H
Arch Esp Urol; 2002 Oct; 55(8):895-9. PubMed ID: 12455279
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
Fruzzetti F; Bersi C; Parrini D; Ricci C; Genazzani AR
Fertil Steril; 1999 Mar; 71(3):445-51. PubMed ID: 10065780
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women.
Carmina E; Lobo RA
Clin Endocrinol (Oxf); 2002 Aug; 57(2):231-4. PubMed ID: 12153602
[TBL] [Abstract][Full Text] [Related]
15. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
Glina S; Roehrborn CG; Esen A; Plekhanov A; Sorsaburu S; Henneges C; Büttner H; Viktrup L
J Sex Med; 2015 Jan; 12(1):129-38. PubMed ID: 25353053
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
Sahin Y; Bayram F; Keleştimur F; Müderris I
J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
[TBL] [Abstract][Full Text] [Related]
17. Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia.
Hochberg DA; Basillote JB; Armenakas NA; Vasovic L; Shevchuk M; Pareek G; Fracchia JA
J Urol; 2002 Apr; 167(4):1731-3. PubMed ID: 11912398
[TBL] [Abstract][Full Text] [Related]
18. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
Lumachi F; Rondinone R
Fertil Steril; 2003 Apr; 79(4):942-6. PubMed ID: 12749435
[TBL] [Abstract][Full Text] [Related]
19. Re: A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride.
Harrison RH
J Urol; 2000 Nov; 164(5):1670-1. PubMed ID: 11203073
[No Abstract] [Full Text] [Related]
20. Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women.
Fung R; Hellstern-Layefsky M; Tastenhoye C; Lega I; Steele L
J Sex Med; 2016 Nov; 13(11):1765-1772. PubMed ID: 27693265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
